Intra Cellular Therapies reported $-69016000 in EBITDA for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -42.78M 23.1M
Aptinyx Inc APTX:US $ -19766000 5.89M
Arena Pharmaceuticals ARNA:US $ -143.42M 12.4M
Biogen BIIB:US $ 991.8M 155.8M
Bristol Myers Squibb BMY:US $ 5679M 455M
Cytokinetics CYTK:US $ -54.25M 14.18M
Esperion Therapeutics ESPR:US $ -32380000 50.29M
Gilead Sciences GILD:US $ 2816M 669M
Gw Pharmaceuticals GWPH:US $ -17.18M 2.02M
Halozyme Therapeutics HALO:US $ 93.85M 42.37M
Intra Cellular Therapies ITCI:US $ -69.02M 15.92M
JAZZ PHA JAZZ:US $ 77.72M 157.36M
Johnson & Johnson JNJ:US $ 8192M 2043M
Marinus Pharmaceuticals MRNS:US $ -23.4M 3.68M
Minerva Neurosciences NERV:US $ -8.96M 1.46M
Nektar Therapeutics NKTR:US $ -106.66M 0.81M
Neurocrine Biosciences NBIX:US $ 70.4M 36.4M
Novartis NVS:US $ 4772M 423M
Prothena PRTA:US 28.24M 60.04M
Redhill Biopharma RDHL:US $ -22.59M 6.76M
Supernus Pharmaceuticals SUPN:US $ 40.06M 20.24M
United Therapeutics UTHR:US $ 234.6M 263.8M
Vanda Pharmaceuticals VNDA:US $ 13.08M 2.02M
Zogenix ZGNX:US $ -53.07M 3.63M